A porcine model of complement activation-related pseudoallergy to nano-pharmaceuticals: Pros and cons of translation to a preclinical safety test
Precision Nanomedicine · 2018
DOI: 10.29016/180427.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Precision Nanomedicine, 2018. Verfasst von János Szebeni und 3 weiteren Autor:innen. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: Seventh Framework Programme.
Abstract (Originalsprache)
Pigs provide a sensitive and quantitative animal model of non-IgE-mediated(pseudoallergic) hypersensitivity reactions (HSRs) caused by liposomes and many other nanoparticulate drugs or drug-carrier nanosystems (nanomedicines). The rapidly arising symptoms, including cardiopulmonary, hemodynamic, hematological, blood chemistry and skin changes, resemble the clinical picture in man undergoing infusion reactions toreactogenic nanoparticles. In addition to summarizing the basic features of the pig CARPA model, thereviewconsiderssome of the advantages and disadvantages of using the modelforpreclinical evaluation of nanomedicine safety.
Förderung
- Seventh Framework Programme
Zitieren
APA
Szebeni, J., Bedőcs, P., Dézsi, L., & Urbanics, R. (2018). A porcine model of complement activation-related pseudoallergy to nano-pharmaceuticals: Pros and cons of translation to a preclinical safety test. Precision Nanomedicine. https://doi.org/10.29016/180427.1
Vancouver
Szebeni J, Bedőcs P, Dézsi L, Urbanics R. A porcine model of complement activation-related pseudoallergy to nano-pharmaceuticals: Pros and cons of translation to a preclinical safety test. Precision Nanomedicine. 2018. doi:10.29016/180427.1
BibTeX
@article{Szebeni2018,
author = {Szebeni, János and Bedőcs, Péter and Dézsi, László and Urbanics, Rudolf},
title = {A porcine model of complement activation-related pseudoallergy to nano-pharmaceuticals: Pros and cons of translation to a preclinical safety test},
journal = {Precision Nanomedicine},
year = {2018},
doi = {10.29016/180427.1}
}
EUVIMED